Clinical services
Article
The innovative surgical program from Optum and MinWorx dramatically reduces total claim costs and claim duration. And its streamlined implementation process results in minimal lift for payers.
Clinical update
At the end of July, the FDA issued a safety alert regarding the risks associated with using opioid analgesics for longer periods of time.
Clinical update
On January 30, 2025, Axsome Therapeutics announced the U.S. FDA approval of Symbravo for the acute treatment of migrane.
White paper
Climate change poses significant health risks for workers. Optum programs work together to address an injured worker’s varied and often codependent needs.
White paper
GLP-1 medications can offer substantial benefits for overweight injured workers. Our clinical and policy experts can help you navigate the evolving GLP-1 landscape.
Article
Formulary management works with the authorization process to support worker safety, reduce complexity, and prevent unintended billing errors.